Cytokines and nitric oxide in islet inflammation and diabetes

Proceedings of the Society for Experimental Biology and Medicine
M L McDanielJ A Corbett

Abstract

Cytokines released by both T lymphocytes and activated macrophages, in particular interleukin-1 (IL-1), have been implicated as immunological effector molecules that both inhibit insulin secretion from the pancreatic beta cell and induce beta-cell destruction. Recent findings have demonstrated that production of the free radical nitric oxide (NO), resulting from the expression of the cytokine-inducible isoform of NO synthase (iNOS), mediates these deleterious effects. The cellular mechanism responsible for inhibition of beta-cell function and destruction by NO involves, in part, inactivation of enzymes specifically localized to the beta-cell mitochondria that contain iron- sulfur centers or clusters. Intraislet release of IL-1 also inhibits beta-cell function by this same cellular mechanism involving the overproduction of NO. In addition, the cytokine, IL-1, induces the co-expression of both iNOS and the cytokine-inducible isoform of cyclooxygenase, COX-2. The expression of COX-2 results in the overproduction of the proinflammatory prostaglandins and thromboxanes. Furthermore, NO produced by iNOS directly stimulates the activities of both constitutive and inducible isoforms of COX, further augmenting the overproduction of these...Continue Reading

Citations

Jun 30, 2000·Biochemical and Biophysical Research Communications·T TabatabaieY Kotake
Oct 18, 2000·Biochemical and Biophysical Research Communications·A SjöholmR V Cooney
May 1, 2001·Biochemical and Biophysical Research Communications·A SjöholmR E Honkanen
Sep 6, 2008·Japanese Journal of Ophthalmology·Izumi YuasaYukitaka Uji
Mar 15, 2005·Journal of Ethnopharmacology·Ming-Jiuan WuTzi-Wei Lian
Jun 25, 2004·Experimental and Molecular Pathology·Aito Yamanouchi-UenoKunio Doi
Jul 1, 1998·Clinical Biochemistry·G EllisS K Makela
Aug 15, 1998·Trends in Pharmacological Sciences·C Szabó, V L Dawson
Nov 25, 2000·Toxicology·E Adeghate, S H Parvez
Jul 20, 2001·Free Radical Biology & Medicine·J W LimK H Kim
Nov 21, 1998·Free Radical Biology & Medicine·I K Mohan, U N Das
Apr 11, 2001·Trends in Endocrinology and Metabolism : TEM·J A Corbett
Sep 16, 1998·Current Opinion in Chemical Biology·B R Babu, O W Griffith
Jul 2, 2003·The Journal of Experimental Medicine·Ursula GrohmannPaolo Puccetti
Sep 8, 2011·Molecular and Cellular Biology·Gordon P MearesJohn A Corbett
Sep 11, 2008·American Journal of Physiology. Endocrinology and Metabolism·Craig S NunemakerJerry L Nadler
Jul 15, 1997·The Journal of Clinical Investigation·M ShimabukuroR H Unger
Oct 6, 1997·The Journal of Clinical Investigation·M ShimabukuroR H Unger
Jun 4, 2008·Folia Histochemica Et Cytobiologica·Nurullah Keklikoglu
Mar 6, 2010·Journal of Endocrinological Investigation·L YuanC-J Qi
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·M O KurrerJ D Katz
Mar 25, 2014·Acta histochemica·Hanan Dawood Yassa, Adel Fathy Tohamy
Jan 8, 2000·Microvascular Research·W G Mayhan, G M Sharpe
Jan 17, 2013·American Journal of Physiology. Endocrinology and Metabolism·Gordon P MearesJohn A Corbett
Jun 2, 2007·Journal of Drug Targeting·A A PalizbanH Galehdari
Aug 2, 2007·Expert Opinion on Biological Therapy·Massimo Trucco, Nick Giannoukakis
Jul 16, 2011·Prostaglandins & Other Lipid Mediators·Pengcheng Luo, Mong-Heng Wang
Oct 7, 2008·Transplant Immunology·Lina Thorvaldson, Stellan Sandler
Jul 9, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Joyce C BregerNam Sun Wang
Sep 15, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ying ZhengZhiguang Zhou
Apr 5, 2002·Biochemical Pharmacology·Anjaneyulu Kowluru, Noel G Morgan
Jul 19, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Mohamed M El-seweidyReem M Hashem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.